Diabetes Research and Clinical Practice
Volume 87, Issue 2 , Pages 150-156 , February 2010

On what evidence-base do we recommend self-monitoring of blood glucose?

  • Hubert Kolb

      Affiliations

    • Hagedorn Research Institute, Niels Steensenvej 6, DK Gentofte, Denmark
    • Corresponding Author InformationCorresponding author. Tel.: +49 17662257211.
    • ,
  • Kerstin Kempf

      Affiliations

    • West-German Centre of Diabetes and Health, Sana Clinics Düsseldorf GmbH, Düsseldorf, Germany
    • ,
  • Stephan Martin

      Affiliations

    • West-German Centre of Diabetes and Health, Sana Clinics Düsseldorf GmbH, Düsseldorf, Germany
    • ,
  • Michael Stumvoll

      Affiliations

    • Department of Medicine, University Hospital Leipzig, Leipzig, Germany
    • ,
  • Rüdiger Landgraf

      Affiliations

    • German Diabetes Foundation, Munich, Germany

Received 3 September 2009 ,Revised 14 October 2009 ,Accepted 22 October 2009.

References 

  1. Worth R, Home PD, Johnston DG, Anderson J, Ashworth L, Burrin JM, et al. Intensive attention improves glycaemic control in insulin-dependent diabetes without further advantage from home blood glucose monitoring: results of a controlled trial. Br. Med. J. (Clin. Res. Ed.). 1982;285:1233–1240
  2. Miller PF, Stratton C, Tripp JH. Blood testing compared with urine testing in the long term control of diabetes. Arch. Dis. Child. 1983;58:294–297
  3. Mann NP, Noronha JL, Johnston DI. A prospective study to evaluate the benefits of long-term self-monitoring of blood glucose in diabetic children. Diabetes Care. 1984;7:322–326
  4. Daneman D, Siminerio L, Transue D, Betschart J, Drash A, Becker D. The role of self-monitoring of blood glucose in the routine management of children with insulin-dependent diabetes mellitus. Diabetes Care. 1985;8:1–4
  5. Terent A, Hagfall O, Cederholm U. The effect of education and self-monitoring of blood glucose on glycosylated hemoglobin in type I diabetes. A controlled 18-month trial in a representative population. Acta Med. Scand. 1985;217:47–53
  6. Gordon D, Semple CG, Paterson KR. Do different frequencies of self-monitoring of blood glucose influence control in type 1 diabetic patients?. Diabet. Med. 1991;8:679–682
  7. Starostina EG, Antsiferov M, Galstyan GR, Trautner C, Jorgens V, Bott U, et al. Effectiveness cost-benefit analysis of intensive treatment and teaching programmes for type 1 (insulin-dependent) diabetes mellitus in Moscow – blood glucose versus urine glucose self-monitoring. Diabetologia. 1994;37:170–176
  8. Carney RM, Schechter K, Homa M, Levandoski L, White N, Santiago J. The effects of blood glucose testing versus urine sugar testing on the metabolic control of insulin-dependent diabetic children. Diabetes Care. 1983;6:378–380
  9. Muhlhauser I, Bruckner I, Berger M, Cheta D, Jorgens V, Ionescu-Tirgoviste C, et al. Evaluation of an intensified insulin treatment and teaching programme as routine management of type 1 (insulin-dependent) diabetes. The Bucharest–Dusseldorf Study. Diabetologia. 1987;30:681–690
  10. Pieber TR, Brunner GA, Schnedl WJ, Schattenberg S, Kaufmann P, Krejs GJ. Evaluation of a structured outpatient group education program for intensive insulin therapy. Diabetes Care. 1995;18:625–630
  11. DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. Br. Med. J. 2002;325:746
  12. DAFNE Study Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group. N. Engl. J. Med. 1993;329:977–986
  13. Reichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N. Engl. J. Med. 1993;329:304–309
  14. Kapoor N, Sankaran S, Hyer S, Shehata H. Diabetes in pregnancy: a review of current evidence. Curr. Opin. Obstet. Gynecol. 2007;19:586–590
  15. Landon MB, Gabbe SG, Piana R, Mennuti MT, Main EK. Neonatal morbidity in pregnancy complicated by diabetes mellitus: predictive value of maternal glycemic profiles. Am. J. Obstet. Gynecol. 1987;156:1089–1095
  16. Langer O, Levy J, Brustman L, Anyaegbunam A, Merkatz R, Divon M. Glycemic control in gestational diabetes mellitus – how tight is tight enough: small for gestational age versus large for gestational age?. Am. J. Obstet. Gynecol. 1989;161:646–653
  17. Jensen DM, Damm P, Moelsted-Pedersen L, Ovesen P, Westergaard JG, Moeller M, et al. Outcomes in type 1 diabetic pregnancies: a nationwide, population-based study. Diabetes Care. 2004;27:2819–2823
  18. Lapolla A, Dalfra MG, Bonomo M, Castiglioni MT, Di Cianni G, Masin M, et al. Can plasma glucose and HbA1c predict fetal growth in mothers with different glucose tolerance levels?. Diabetes Res. Clin. Pract. 2007;77:465–470
  19. Metzger BE, Lowe LP, Dyer AR, Trimble ER, Chaovarindr U, Coustan DR, et al. Hyperglycemia and adverse pregnancy outcomes. N. Engl. J. Med. 2008;358:1991–2002
  20. Crowther CA, Hiller JE, Moss JR, McPhee AJ, Jeffries WS, Robinson JS. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. N. Engl. J. Med. 2005;352:2477–2486
  21. Kinsley B. Achieving better outcomes in pregnancies complicated by type 1 and type 2 diabetes mellitus. Clin. Ther. 2007;29(Suppl D):S153–S160
  22. Nicholson WK, Wilson LM, Witkop CT, Baptiste-Roberts K, Bennett WL, Bolen S, et al. Therapeutic management, delivery, and postpartum risk assessment and screening in gestational diabetes. Evid. Rep. Technol. Assess. (Full. Rep.). 2008;1–96
  23. Hanson U, Persson B, Enochsson E, Lennerhagen P, Lindgren F, Lundstrom V, et al. Self-monitoring of blood glucose by diabetic women during the third trimester of pregnancy. Am. J. Obstet. Gynecol. 1984;150:817–821
  24. Stubbs SM, Brudenell JM, Pyke DA, Watkins PJ, Stubbs WA, Alberti KG. Management of the pregnant diabetic: home or hospital, with or without glucose meters?. Lancet. 1980;1:1122–1124
  25. Goldberg JD, Franklin B, Lasser D, Jornsay DL, Hausknecht RU, Ginsberg-Fellner F, et al. Gestational diabetes: impact of home glucose monitoring on neonatal birth weight. Am. J. Obstet. Gynecol. 1986;154:546–550
  26. Varner MW. Efficacy of home glucose monitoring in diabetic pregnancy. Am. J. Med. 1983;75:592–596
  27. de Veciana M, Major CA, Morgan MA, Asrat T, Toohey JS, Lien JM, et al. Postprandial versus preprandial blood glucose monitoring in women with gestational diabetes mellitus requiring insulin therapy. N. Engl. J. Med. 1995;333:1237–1241
  28. Homko CJ, Sivan E, Reece EA. The impact of self-monitoring of blood glucose on self-efficacy and pregnancy outcomes in women with diet-controlled gestational diabetes. Diabetes Educ. 2002;28:435–443
  29. Murphy HR, Rayman G, Lewis K, Kelly S, Johal B, Duffield K, et al. Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. Br. Med. J. 2008;337:a1680
  30. Schaefer-Graf UM, Kjos SL, Fauzan OH, Buhling KJ, Siebert G, Buhrer C, et al. A randomized trial evaluating a predominantly fetal growth-based strategy to guide management of gestational diabetes in Caucasian women. Diabetes Care. 2004;27:297–302
  31. Wing RR, Epstein LH, Nowalk MP, Scott N, Koeske R, Hagg S. Does self-monitoring of blood glucose levels improve dietary compliance for obese patients with type II diabetes?. Am. J. Med. 1986;81:830–836
  32. Fontbonne A, Billault B, Acosta M, Percheron C, Varenne P, Besse A, et al. Is glucose self-monitoring beneficial in non-insulin-treated diabetic patients? Results of a randomized comparative trial. Diabetes Metab. 1989;15:255–260
  33. Allen BT, DeLong ER, Feussner JR. Impact of glucose self-monitoring on non-insulin-treated patients with type II diabetes mellitus. Randomized controlled trial comparing blood and urine testing. Diabetes Care. 1990;13:1044–1050
  34. Estey AL, Tan MH, Mann K. Follow-up intervention: its effect on compliance behavior to a diabetes regimen. Diabetes Educ. 1990;16:291–295
  35. Rutten G, van Eijk J, de Nobel E, Beek M, van der Helden H. Feasibility and effects of a diabetes type II protocol with blood glucose self-monitoring in general practice. Fam. Pract. 1990;7:273–278
  36. Muchmore DB, Springer J, Miller M. Self-monitoring of blood glucose in overweight type 2 diabetic patients. Acta Diabetol. 1994;31:215–219
  37. Jaber LA, Halapy H, Fernet M, Tummalapalli S, Diwakaran H. Evaluation of a pharmaceutical care model on diabetes management. Ann. Pharmacother. 1996;30:238–243
  38. Miles P, Everett J, Murphy J, Kerr D. Comparison of blood or urine testing by patients with newly diagnosed non-insulin dependent diabetes: patient survey after randomised crossover trial. Br. Med. J. 1997;315:348–349
  39. Kibriya MG, Ali L, Banik NG, Khan AK. Home monitoring of blood glucose (HMBG) in type-2 diabetes mellitus in a developing country. Diabetes Res. Clin. Pract. 1999;46:253–257
  40. Brown SA, Garcia AA, Kouzekanani K, Hanis CL. Culturally competent diabetes self-management education for Mexican Americans: the Starr County border health initiative. Diabetes Care. 2002;25:259–268
  41. Guerci B, Drouin P, Grange V, Bougneres P, Fontaine P, Kerlan V, et al. Self-monitoring of blood glucose significantly improves metabolic control in patients with type 2 diabetes mellitus: the Auto-Surveillance Intervention Active (ASIA) study. Diabetes Metab. 2003;29:587–594
  42. Jones H, Edwards L, Vallis TM, Ruggiero L, Rossi SR, Rossi JS, et al. Changes in diabetes self-care behaviors make a difference in glycemic control: the Diabetes Stages of Change (DiSC) study. Diabetes Care. 2003;26:732–737
  43. Kwon HS, Cho JH, Kim HS, Song BR, Ko SH, Lee JM, et al. Establishment of blood glucose monitoring system using the Internet. Diabetes Care. 2004;27:478–483
  44. Cho JH, Chang SA, Kwon HS, Choi YH, Ko SH, Moon SD, et al. Long-term effect of the Internet-based glucose monitoring system on HbA1c reduction and glucose stability: a 30-month follow-up study for diabetes management with a ubiquitous medical care system. Diabetes Care. 2006;29:2625–2631
  45. Johnson JA, Majumdar SR, Bowker SL, Toth EL, Edwards A. Self-monitoring in Type 2 diabetes: a randomized trial of reimbursement policy. Diabet. Med. 2006;23:1247–1251
  46. Moreland EC, Volkening LK, Lawlor MT, Chalmers KA, Anderson BJ, Laffel LM. Use of a blood glucose monitoring manual to enhance monitoring adherence in adults with diabetes: a randomized controlled trial. Arch. Intern. Med. 2006;166:689–695
  47. Siebolds M, Gaedeke O, Schwedes U. Self-monitoring of blood glucose – psychological aspects relevant to changes in HbA1c in type 2 diabetic patients treated with diet or diet plus oral antidiabetic medication. Patient Educ. Couns. 2006;62:104–110
  48. Simon J, Gray A, Clarke P, Wade A, Neil A, Farmer A. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial. Br. Med. J. 2008;336:1177–1180
  49. Farmer AJ, Wade AN, French DP, Simon J, Yudkin P, Gray A, et al. Blood glucose self-monitoring in type 2 diabetes: a randomised controlled trial. Health Technol. Assess. 2009;13:iii–xi, 1
  50. Scherbaum WA, Ohmann C, Abholz HH, Dragano N, Lankisch M. Effect of the frequency of self-monitoring blood glucose in patients with type 2 diabetes treated with oral antidiabetic drugs-a multi-centre, randomized controlled trial. PLoS One. 2008;3:e3087
  51. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am. J. Med. 2005;118:422–425
  52. Farmer A, Wade A, Goyder E, Yudkin P, French D, Craven A, et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial. Br. Med. J. 2007;335:132
  53. O’Kane MJ, Bunting B, Copeland M, Coates VE. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial. Br. Med. J. 2008;336:1174–1177
  54. Schwedes U, Siebolds M, Mertes G. Meal-related structured self-monitoring of blood glucose: effect on diabetes control in non-insulin-treated type 2 diabetic patients. Diabetes Care. 2002;25:1928–1932
  55. Barnett AH, Krentz AJ, Strojek K, Sieradzki J, Azizi F, Embong M, et al. The efficacy of self-monitoring of blood glucose in the management of patients with type 2 diabetes treated with a gliclazide modified release-based regimen. A multicentre, randomized, parallel-group, 6-month evaluation (DINAMIC 1 study). Diabetes Obes. Metab. 2008;10:1239–1247
  56. Bergenstal RM, Gavin JR. The role of self-monitoring of blood glucose in the care of people with diabetes: report of a global consensus conference. Am. J. Med. 2005;118:1S–6S
  57. Peter R, Okoseime OE, Rees A, Owens DR. Postprandial glucose – a potential therapeutic target to reduce cardiovascular mortality. Curr. Vasc. Pharmacol. 2009;7:68–74
  58. Davidson MB. Counterpoint: self-monitoring of blood glucose in type 2 diabetic patients not receiving insulin: a waste of money. Diabetes Care. 2005;28:1531–1533
  59. Ceriello A, Colagiuri S. International Diabetes Federation guideline for management of postmeal glucose: a review of recommendations. Diabet. Med. 2008;25:1151–1156
  60. Kempf K, Neukirchen W, Martin S, Kolb H. Self-monitoring of blood glucose in type 2 diabetes: a new look at published trials. Diabetologia. 2008;51:686–688
  61. McAndrew L, Schneider SH, Burns E, Leventhal H. Does patient blood glucose monitoring improve diabetes control? A systematic review of the literature. Diabetes Educ. 2007;33:991–1011
  62. McGeoch G, Derry S, Moore RA. Self-monitoring of blood glucose in type-2 diabetes: what is the evidence?. Diabetes Metab. Res. Rev. 2007;23:423–440
  63. Poolsup N, Suksomboon N, Jiamsathit W. Systematic review of the benefits of self-monitoring of blood glucose on glycemic control in type 2 diabetes patients. Diabetes Technol. Ther. 2009;10(Suppl. 1):S-51–S-66
  64. UKPDS Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:837–853
  65. UKPDS Group. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group. Lancet. 1998;352:854–865
  66. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br. Med. J. 2000;321:405–412
  67. Ohkubo Y, Kishikawa H, Araki E, Miyata T, Isami S, Motoyoshi S, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res. Clin. Pract. 1995;28:103–117
  68. Shichiri M, Kishikawa H, Ohkubo Y, Wake N. Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients. Diabetes Care. 2000;23(Suppl 2):B21–B29
  69. ADVANCE Collaborative GroupPatel A, MacMahon S, Chalmers J, Neal B, Billot L, et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. N. Engl. J. Med. 2008;358:2560–2572
  70. Del Prato S. Megatrials in type 2 diabetes. From excitement to frustration?. Diabetologia. 2009;52:1219–1226
  71. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al. Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet. 2009;373:1765–1772
  72. Donnelly LA, Morris AD, Frier BM, Ellis JD, Donnan PT, Durrant R, et al. Frequency and predictors of hypoglycaemia in type 1 and insulin-treated Type 2 diabetes: a population-based study. Diabet. Med. 2005;22:749–755
  73. Cryer PE. The barrier of hypoglycemia in diabetes. Diabetes. 2008;57:3169–3176
  74. Amiel SA, Dixon T, Mann R, Jameson K. Hypoglycaemia in type 2 diabetes. Diabet. Med. 2008;25:245–254
  75. Whitmer RA, Karter AJ, Yaffe K, Quesenberry CP, Selby JV. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. JAMA. 2009;301:1565–1572
  76. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N. Engl. J. Med. 2005;353:2643–2653
  77. Holman RR, Paul SK, Bethel MA, Matthews DR, Neil HA. 10-year follow-up of intensive glucose control in type 2 diabetes. N. Engl. J. Med. 2008;359:1577–1589

☆ Roche Diagnostics provided the basis for a discussion platform for the authors and the colleagues acknowledged, by an unrestricted grant. Hubert Kolb, Kerstin Kempf and Stephan Martin received previous support by Roche Diagnostics, Menarini (H.K.) and Terumo (S.M.).

PII: S0168-8227(09)00462-8

doi: 10.1016/j.diabres.2009.10.014

Diabetes Research and Clinical Practice
Volume 87, Issue 2 , Pages 150-156 , February 2010

Article Tools